RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Income Statement
Balance Sheet
Cash Flow

Income Statement

Currency in USD. All numbers in thousands
Total Revenue4,0071013
Cost of Revenue2,126--
Gross Profit1,8811013
Operating Expenses
Research Development32,96925,24117,771
Selling General and Administrative20,8845,4034,234
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-51,972-30,543-22,002
Income from Continuing Operations
Total Other Income/Expenses Net6,5051,5481,124
Earnings Before Interest and Taxes-45,467-28,995-20,878
Interest Expense77375212
Income Before Tax-45,544-29,370-21,090
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-45,544-29,370-21,090
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-45,544-29,370-21,090
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-45,544-29,370-21,090